Undertaking for non-applicability of disclosure under Reg 23 of SEBI (LODR) Regulations, 2015 w.r.t related party transaction.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Clinitech Laboratory Ltd has submitted an undertaking to BSE stating that the disclosure requirements under Regulation 23 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, dealing with related party transactions, are not applicable to the company. Regulation 23 normally requires listed companies to disclose material related party transactions and seek shareholder/audit committee approvals. By filing this non-applicability undertaking, the company is effectively communicating that it either has no reportable related party transactions or falls outside the scope of the regulation. The actual filing document was not accessible (BSE page returned an error), so details beyond the headline could not be verified.
This is a routine compliance communication and is generally neutral for shareholders. It suggests the company either has no significant related party dealings or is exempt from the disclosure norm, and is unlikely to cause any meaningful movement in the stock price.